Mineralys Therapeutics Ownership | Who Owns Mineralys Therapeutics?

Overview ForecastFinancials Chart Transcripts

Mineralys Therapeutics Ownership Summary

Mineralys Therapeutics is owned by 120.87% institutional investors, 0.67% insiders. Catalys pacific is the largest institutional shareholder, holding 9.54% of MLYS shares. American Funds SMALLCAP World A is the top mutual fund, with 2.83% of its assets in Mineralys Therapeutics shares.

MLYS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Mineralys Therapeutics	120.87%	0.67%	-21.54%
Sector	Healthcare Stocks	246.48%	12.12%	-158.60%
Industry	Biotech Stocks	384.82%	11.76%	-296.58%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Catalys pacific	7.90M	9.54%	$213.25M
Ra capital management	7.69M	9.29%	$207.55M
Blackrock funding, inc. /de	5.89M	7.11%	$158.83M
Samsara biocapital	5.87M	7.09%	$158.40M
Fmr	4.51M	5.45%	$121.73M
State street	4.14M	5.00%	$111.74M
Deerfield management company, l.p. (series c)	3.96M	4.78%	$106.79M
Vanguard group	3.35M	4.75%	$121.68M
Vanguard capital management	2.76M	3.33%	$74.38M
Laurion capital management lp	2.51M	3.03%	$67.62M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Catalys pacific	7.90M	92.94%	$213.25M
Andera partners	1.59M	22.77%	$40.00M
Samsara biocapital	5.87M	13.01%	$158.40M
Sphera funds management	1.47M	5.17%	$39.66M
Troluce capital advisors	1.73M	4.80%	$46.64M
Sr one capital management, lp	1.56M	4.06%	$42.20M
Davern capital partners, lp	858.75K	3.95%	$23.17M
Catalio capital management, lp	648.72K	3.29%	$17.50M
22nw, lp	113.84K	2.93%	$3.07M
Stempoint capital lp	602.69K	2.80%	$16.26M

Top Buyers

Holder	Shares	% Assets	Change
Deerfield management company, l.p. (series c)	3.96M	1.11%	3.96M
Capital world investors	2.00M	0.01%	1.60M
Blackrock funding, inc. /de	5.89M	0.00%	1.41M
State street	4.14M	0.00%	1.21M
Ghisallo capital management	1.13M	0.60%	1.13M

Top Sellers

Holder	Shares	% Assets	Change
Caligan partners lp	-	-	-2.77M
Wellington management group llp	806.72K	0.00%	-2.55M
Tcg crossover management	-	-	-2.47M
Point72 asset management	-	-	-1.91M
Holocene advisors, lp	-	-	-1.60M

New Positions

Holder	Shares	% Assets	Change	Value
Deerfield management company, l.p. (series c)	3.96M	1.11%	3.96M	$106.79M
Ghisallo capital management	1.13M	0.60%	1.13M	$30.35M
Logos global management lp	1.05M	1.22%	1.05M	$28.33M
Abrdn	689.24K	0.03%	689.24K	$18.60M
Sixth street partners management company	521.22K	0.00%	521.22K	$14.06M

Sold Out

Holder	Change
Jpl wealth management	-3.00
Quadrant capital group	-5.00
Clearstead advisors	-11.00
Skopos labs	-26.00
Golden state wealth management	-32.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	239	4.37%	100,122,304	10.85%	120	0.68%	120	-9.77%	71	36.54%
Mar 31, 2026	72	-69.75%	10,534,267	-88.08%	15	0.10%	40	-70.59%	18	-75.34%
Dec 31, 2025	143	-28.50%	40,919,125	-48.50%	57	0.39%	86	-23.89%	44	-29.03%
Sep 30, 2025	193	15.57%	76,304,723	16.16%	116	1.16%	109	-9.17%	59	118.52%
Jun 30, 2025	166	3.75%	65,673,217	7.91%	100	0.77%	119	9.17%	27	-3.57%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
American Funds SMALLCAP World A	2.50M	2.83%	558.39K
Vanguard Health Care Inv	1.86M	2.25%	1.86M
Vanguard Total Stock Mkt Idx Inv	1.97M	2.23%	189.02K
Vanguard Morn Total Stk Mkt Idx Investor	1.97M	2.23%	189.02K
Vanguard MStar Total Stk Mkt Idx Invest	1.97M	2.23%	-
iShares Russell 2000 ETF	1.58M	1.79%	-18.24K
State Street® SPDR® S&P® Biotech ETF	1.48M	1.67%	-28.25K
Polar Capital Biotech S Inc	1.35M	1.52%	-
Fidelity Select Health Care	1.18M	1.33%	-
HBM Healthcare Investments AG Ord	1.14M	1.29%	355.43K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 30, 2026	Congleton Jon	Chief Executive Officer	Sell	$1.91M
Sep 22, 2026	Slingsby Brian Taylor	-	Sell	$3.01M
Sep 21, 2026	Warren Eric	Chief Commercial Officer	Sell	$209.14K
Sep 15, 2026	Karydas Daphne	-	Sell	$85.74K
Aug 21, 2026	Warren Eric	Chief Commercial Officer	Sell	$193.19K

Insider Transactions Trends

Date	Buy	Sell
2026 Q4	-	-
2026 Q3	-	12
2026 Q2	-	17
2026 Q1	2	27
2025 Q4	-	28

MLYS Ownership FAQ

Who Owns Mineralys Therapeutics?

Mineralys Therapeutics shareholders are primarily institutional investors at 120.87%, followed by 0.67% insiders and -21.54% retail investors. The average institutional ownership in Mineralys Therapeutics's industry, Biotech Stocks , is 384.82%, which Mineralys Therapeutics falls below.

Who owns the most shares of Mineralys Therapeutics?

Mineralys Therapeutics’s largest shareholders are Catalys pacific (7.9M shares, 9.54%), Ra capital management (7.69M shares, 9.29%), and Blackrock funding, inc. /de (5.89M shares, 7.11%). Together, they hold 25.94% of Mineralys Therapeutics’s total shares outstanding.

Does Blackrock own Mineralys Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Mineralys Therapeutics.

Who is Mineralys Therapeutics’s biggest shareholder by percentage of total assets invested?

Catalys pacific is Mineralys Therapeutics’s biggest shareholder by percentage of total assets invested, with 92.94% of its assets in 7.9M Mineralys Therapeutics shares, valued at 213.25M$.

Who is the top mutual fund holder of Mineralys Therapeutics shares?

American Funds SMALLCAP World A is the top mutual fund holder of Mineralys Therapeutics shares, with 2.83% of its total shares outstanding invested in 2.5M Mineralys Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools